News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acasti Pharma Closes $2,000,000 CDN Private Placement


2/13/2012 10:05:59 AM

LAVAL, Quebec, Feb. 13, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO) announces that further to its news release dated February 7, 2012, it has closed a private placement pursuant to which Dr. Harlan Waksal, Acasti's Executive Vice-President, Business & Scientific Affairs, and Neptune Technologies & Bioressources Inc. ("Neptune"), Acasti's parent company, have subscribed to Acasti's capital stocks for total net proceeds of approximately $2,000,000 CDN (the "Offering").

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES